Berrie Goldman practices in the Intellectual Property Client Service Group at Bryan Cave LLP. Ms. Goldman concentrates her work on strategic patent counseling, patent preparation and prosecution, IP transactional matters, and patent litigation.

Ms. Goldman advises clients on patent validity, infringement, enforceability, and freedom to operate, including rendering patentability and product clearance opinions, and coordinates the filing and prosecution of patent applications in the United States and abroad. She regularly performs and directs intellectual property due diligence in connection with mergers, acquisitions, and other liquidity events. Ms. Goldman’s experience includes a wide range of technical fields, including agriculture, biotechnology, chemistry and electrochemistry, consumer products, medical devices, nutraceuticals, and pharmaceuticals.

Ms. Goldman is also an experienced patent litigator, having been a member of trial and appellate teams representing both patent owners and patent defendants. Ms. Goldman has litigated disputes involving pharmaceuticals, nutraceuticals, mechanical devices, and consumer products. Her experience extends to all phases of patent litigation, including bench and jury trials encompassing patent validity, infringement, and enforceability, as well as appellate proceedings before the Federal Circuit.

Ms. Goldman is a registered patent attorney and holds a degree in Biomedical Physics.

Professional Affiliations

    • San Francisco Intellectual Property Law Association (SFIPLA)
    • American Bar Association, Intellectual Property Section
    • Bar Association of San Francisco
    • American Bar Association, Intellectual Property Section
    • Bar Association of San Francisco
    • Bar Association of San Francisco
Read More

Representative Experience

Ms. Goldman’s practice experience includes, but is not limited to, the following technical areas:

  • Agricultural materials and processes, including polymeric fertilizers and grain-based ethanol production
  • Cancer therapies and diagnostics
  • Electrochemical devices, including electrochemical substrates and films
  • Food and beverage ingredients and equipment
  • Garment and apparel manufacturing
  • Medical devices, including active and passive transdermal drug delivery systems
  • Nutraceuticals and plant-based topical compositions
  • Small organic molecules and polymers for a range of medical conditions

Representative litigation matters on which Ms. Goldman has worked include:

  • CreAgri, Inc. v. Pinnaclife, Inc. (N.D. Cal.) (Defended nutritional supplement company against allegations of infringement of multiple patents ultimately invalidated on summary judgment)
  • SA Recycling LLC v. Kramar’s Iron & Metal, Inc. (C.D. Cal.) (Represented Plaintiff in a patent infringement action relating to metal recycling technology)
  • Alzheimer’s Institute of America, Inc. v. Avid Radiopharmaceuticals (E.D. Pa.) (Member of the trial and appellate team representing Plaintiff in patent infringement action relating to therapeutic screening and target validation for Alzheimer’s disease)
  • Karecki v. Mayfair Tech, Inc. (S.D. Cal.) (Defended women’s shapewear company against allegations of patent infringement by competitor)
  • Backgate Designs, Inc. v. CBB Group Inc. (N.D. Cal.) (Lead counsel representing Plaintiff in patent infringement action relating to consumer products)
  • Bare Escentuals Beauty, Inc. v. Intelligent Beauty, LLC (N.D. Cal.) (Defended cosmetics company against allegations of trademark infringement)
  • Amgen Inc. v. F. Hoffman La Roche (D. Mass.) (Member of the trial team representing Plaintiff in Declaratory Judgment Action involving multiple patents relating to recombinant human cytokine)
  • Represented multi-national financial institutions in commercial litigation matters.


  • “Phamacogenomics: Privacy in the Era of Personalized Medicine,” Northwestern Journal of Technology and Intellectual Property, 4 NW. J. Tech & Intell. Prop. 83